Suppr超能文献

增生性和多中心性肾母细胞瘤病的保守治疗

Conservative management of hyperplastic and multicentric nephroblastomatosis.

作者信息

Cozzi Francesco, Schiavetti Amalia, Cozzi Denis A, Morini Francesco, Uccini Stefania, Pierani Paolo, Martino Ascanio

机构信息

Pediatric Surgery Unit, Department of Experimental Medicine and Pathology, University of Rome La Sapienza, Rome, Italy.

出版信息

J Urol. 2004 Sep;172(3):1066-9; discussion 1069-70. doi: 10.1097/01.ju.0000134883.12993.82.

Abstract

PURPOSE

The treatment of hyperplastic nephroblastomatosis remains controversial. We report the advantages of conservative management of hyperplastic and multicentric nephroblastomatosis associated with unilateral Wilms tumor (WT).

MATERIALS AND METHODS

During the last 10 years 48 children with unilateral WT were consecutively treated at our 2 institutions. Children with multiple solid renal masses on imaging were treated with 2-drug chemotherapy until disappearance of the lesions. Stabilization or progression of the lesions despite chemotherapy, as well as heterogeneity of the lesions on imaging, prompted nephron sparing surgery (NSS).

RESULTS

Three female infants (12, 13 and 20 months old, respectively) presented with multiple solid renal tumors at imaging. Despite chemotherapy, small and unilateral WT developed in 2 cases of hyperplastic nephroblastomatosis, which was excised. One of these infants subsequently presented with a small contralateral metachronous WT, which was excised. Both infants are disease-free with 2 normal kidneys at followup of 6 and 2 years, respectively. The third infant, who presented with unilateral multicentric WT and unilateral hyperplastic nephroblastomatosis nodules, was successfully treated with preoperative chemotherapy and enucleation of 5 tumors. Subsequently, nephrectomy was performed at another institution because the abnormal kidney outline due to NSS was misinterpreted as a recurrence of WT. She was lost to followup.

CONCLUSIONS

Hyperplastic and multicentric nephroblastomatosis is not a rare lesion and is most often associated, either initially or subsequently, with WT. In some infants with multiple solid renal masses on imaging chemotherapy and for developing WT NSS may safely allow maximum sparing of the parenchyma of both kidneys.

摘要

目的

增生性肾母细胞瘤病的治疗仍存在争议。我们报告了对与单侧肾母细胞瘤(WT)相关的增生性和多中心性肾母细胞瘤病进行保守治疗的优势。

材料与方法

在过去10年中,我们两家机构连续治疗了48例单侧WT患儿。对影像学检查发现有多个实性肾肿块的患儿采用两药化疗,直至病灶消失。尽管进行了化疗,但病灶仍稳定或进展,以及影像学上病灶的异质性,促使进行保留肾单位手术(NSS)。

结果

3名女婴(分别为12、13和20个月大)在影像学检查中发现有多个实性肾肿瘤。尽管进行了化疗,但2例增生性肾母细胞瘤病患儿仍发展为小的单侧WT,并进行了切除。其中1名婴儿随后出现对侧小的异时性WT,也进行了切除。两名婴儿在分别随访6年和2年时均无疾病,双肾正常。第三名婴儿表现为单侧多中心WT和单侧增生性肾母细胞瘤病结节,经术前化疗和摘除5个肿瘤成功治疗。随后,由于NSS导致的异常肾轮廓被误诊为WT复发,该婴儿在另一机构接受了肾切除术。她失访了。

结论

增生性和多中心性肾母细胞瘤病并非罕见病变,最常最初或随后与WT相关。对于一些影像学检查发现有多个实性肾肿块的婴儿,化疗以及针对发展中的WT进行NSS可安全地最大限度保留双肾实质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验